Kenneth Hallows, PhD
Nephrology · Burlington, VTNPI 1043283997
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,788 of the $14,357 with a category attached, or 96.0%. Otsuka Pharmaceutical Development & Commercialization, Inc. accounts for 65.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $10,463 and has fallen 65.1% since, to $3,654 in 2024.
Across 9 payments — averaging $1595.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$9K
- Esperion Therapeutics, Inc.$4K
- Aurinia Pharma U.S., Inc.$871
- Amgen$125
- Akebia Therapeutics Inc$121
- Vifor Pharma, Inc.$119
- plus $83 from 1 others
What the payments were for
- Consulting fees$13,78896%
- Food & beverage$5694%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $9,384 |
| Esperion Therapeutics, Inc. | 1 | $3,654 |
| Aurinia Pharma U.S., Inc. | 2 | $871 |
| Amgen | 1 | $125 |
| Akebia Therapeutics Inc | 1 | $121 |
| Vifor Pharma, Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 2 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few nephrology providers in Vermontto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Burlington
- Macaulay OnuigboBurlington$25K
- Nuria Pastor SolerBurlington$15K
- Richard SolomonBurlington$10K
- Abhishek KumarBurlington$509
- Silviana MarineciBurlington$249
- Virginia HoodBurlington$0
- Jeffrey RimmerBurlington$0
- Alison FitzgeraldBurlington$0
- Robert RobeyWhite River Jct$483
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.